(Q42527795)

1 November 2017

title

D-methionine provides excellent protection from cisplatin ototoxicity in the rat. (English)

1 reference

1 November 2017

1 reference

1 reference

Campbell KC

1

1 reference

1 November 2017

Rybak LP

series ordinal

2

1 reference

1 November 2017

Meech RP

series ordinal

3

1 reference

1 November 2017

Hughes L

series ordinal

4

1 reference

1 November 2017

publication date

1 December 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

102

1 reference

1 November 2017

issue

1-2

1 reference

1 November 2017

page(s)

90-98

1 reference

Some procedures to reduce cis-platinum toxicity reduce antitumour activity

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Exacerbation of cisplatin-induced nephrotoxicity by methionine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Protection against cisplatin toxicity by administration of glutathione ester

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cisplatin: evaluation of its ototoxic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Phase I trial of escalating doses of cisplatin in hypertonic saline

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Modification of cisplatin toxicity with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

High-dose cisplatin in patients with advanced malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Early detection of cisplatin ototoxicity. Selected case reports.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

High-dose cisplatin in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Drug-induced ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Correlations between cis-platinum dosage and toxicity in a guinea pig model

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Comparative Value of L-, DL-, and D-Methionine Supplementation of an Oat-based Diet for Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

The ototoxic effect of cisplatin on guinea pigs in relation to dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cisplatin ototoxicity in gynecologic cancer patients. A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Uptake of 11C-L- and D-methionine in brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

High-dose cisplatin with sodium thiosulfate protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Utilization of d-methionine during total parenteral nutrition in postsurgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Phase I Clinical and Pharmacokinetic Study of Diethyldithiocarbamate as a Chemoprotector From Toxic Effects of Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Mechanism of cisplatin ototoxicity: antioxidant system.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Mechanism of Protection by Diethyldithiocarbamate against Cisplatin Ototoxicity: Antioxidant System

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Ototoxicity of low- and moderate-dose cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Effects of equimolar doses of L-methionine, D-methionine and L-methionine-dl-sulfoxide on plasma and urinary amino acid levels in normal adult humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Phase I study of the combination of disulfiram with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Pharmacological interventions to reduce platinum-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5955%2896%2900152-9

7 January 2021

10.1016/S0378-5955(96)00152-9

Identifiers

DOI

1 reference

1 November 2017

1 reference